Suchergebnisse - "Buti, Maria"

PubPharm (637)

21

The elimination of hepatitis D as a public health problem : Needs and challenges

enthalten in: Journal of viral hepatitis | 2024

von Vanwolleghem, T. | Armstrong, P. | Buti, M. | +4

22

Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Fung, S. | Pan, C. | Wong, G. | +17

23

Editorial : Liver elastography for chronic hepatitis D—the end of liver biopsy?

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Buti, M. | Palom, A. | Riveiro‐Barciela, M.

24

An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Riveiro‐Barciela, M. | Barreira‐Díaz, A. | Salcedo, M. | +16

25

The elimination of hepatitis D as a public health problem : Needs and challenges

enthalten in: Journal of Viral Hepatitis | 2024

von Vanwolleghem, T. | Armstrong, P. | Buti, M. | +4

26

Pretreatment gamma‐glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs

enthalten in: The Kaohsiung Journal of Medical Sciences | 2024

von Jang, T. | Liang, P. | Jun, D. | +40

27

Assessing the rate of non‐linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK‐B study

enthalten in: Liver International | 2024

von Feliu‐Prius, A. | Barreira‐Díaz, A. | Rando, A. | +8

28

Management of chronic HBV‐HDV patients chronic HBV‐HDV infection : A review on new management options

enthalten in: United European Gastroenterology Journal | 2024

von Buti, M. | Gonzalez, A. | Riveiro‐Barciela, M. | +1

29

Integrating viral hepatitis management into the emergency department : A further step towards viral hepatitis elimination

enthalten in: JHEP reports : innovation in hepatology | 2024

von Llaneras, J. | Ruiz-Cobo, J. | Rando-Segura, A. | +16

30

HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy

enthalten in: Gastroenterology | 2024

von Sonneveld, M. | Chiu, S. | Park, J. | +26